Mark Lackner
Chief Tech/Sci/R&D Officer at ZENTALIS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 30/04/2024
Profile
Mark Lackner is currently the Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. He previously worked as the VP, Head-Biology & Translational Sciences at IDEAYA Biosciences, Inc. Dr. Lackner obtained his doctorate degree from Stanford University in 1997.
He also holds undergraduate and graduate degrees from the University of Illinois At Urbana–Champaign, which were conferred in 1990 and 1991 respectively.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/02/2024 | 195,728 ( 0.28% ) | 2 M $ | 30/04/2024 |
Mark Lackner active positions
| Companies | Position | Start |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2023 |
Former positions of Mark Lackner
| Companies | Position | End |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Mark Lackner
| Stanford University | Doctorate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Mark Lackner
